Nigeria Confirms Imported Ebola Case in Abuja, Tracks 44 Contacts
Nigeria has confirmed an imported Ebola case in Abuja, prompting an urgent national response. Health authorities are conducting intensive contact tracing, isolating 44 individuals, and enhancing surveillance at entry points, while Uganda clarifies the patient's travel history through its territory. The government is mobilizing resources and drawing on past experience, backed by international support and legislative calls for immediate funding and strengthened health measures.
Nigeria confirmed its first imported case of Ebola virus disease (EVD) in the Federal Capital Territory on October 20, 2026, prompting intensified contact tracing and public health surveillance.
According to the World Health Organisation (WHO), the patient is a woman whose symptoms began on October 7, four days after her arrival in Nigeria; she sought treatment at a private hospital in Abuja on October 11 before laboratory tests confirmed the infection. The case involves the Bundibugyo virus, linked to an ongoing outbreak in the Democratic Republic of the Congo (DRC), and the patient is receiving medical care in isolation.
Health authorities have identified 44 contacts, including healthcare workers, patients, caregivers and travel-related contacts, who are being monitored, with officials treating the case as imported rather than evidence of community transmission.
The patient’s travel history has prompted questions about where the infection occurred, but transit through Uganda does not establish that she contracted the virus there. Ugandan officials said the country had no active Ebola outbreak when the case was announced, while investigations continued into the woman’s movements and possible exposure, including reported travel to eastern DRC.
Ebola is not airborne; transmission occurs primarily through direct contact with the blood or other body fluids of an infected person who has developed symptoms, or through contaminated materials, when the virus enters the body through broken skin or mucous membranes. The incubation period ranges from two to 21 days, and early symptoms can include fever, headache, fatigue, muscle pain, vomiting and diarrhoea; bleeding is not always present, and no licensed vaccine is available for the Bundibugyo virus.
The WHO has pledged support for case investigation, contact tracing, infection prevention and control, and the provision of protective equipment, while advising against blanket travel or trade restrictions.
Nigeria has stepped up surveillance at airports and other entry points, with the Federal Government, the Nigeria Centre for Disease Control and Prevention (NCDC), port health services and aviation authorities coordinating the response. The Senate has called for emergency funding from the Service-Wide Vote and mandatory health screening at international airports, seaports and designated land borders, including health declaration forms, temperature checks and symptom assessments; it also urged improved staffing, equipment and isolation facilities and a review of the Quarantine Act of 1926.
Separately, the House of Representatives urged the Federal Government to release outstanding appropriated funds for health agencies, strengthen infection prevention and control, and improve public awareness and healthcare-worker preparedness. These measures follow the expanding Bundibugyo outbreak in the DRC, which had recorded 8,728 confirmed cases and 4,205 deaths as of October 6, while Kenya has also reported an imported case and subsequent infections; Nigerian authorities continue to call for public cooperation and vigilance as contact tracing and investigations proceed.